Casandra
Casandra Test Code QD79928Version 1 (DRAFT)
Performing Lab
Carisoprodol and Metabolite, Serum, Plasma or Blood
Clinical Use
Order TestUse
This test is intended for therapeutic drug monitoring of carisoprodol and its metabolite meprobamate, providing quantitative measurements in serum, plasma, or whole blood to assist clinicians in evaluating patient exposure and metabolism of the muscle relaxant.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Other
Biomarkers
Carisoprodol
AnalyteCarisoprodol • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Meprobamate
AnalyteMeprobamate • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
3-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL serum (no gel)
Minimum Volume
1 mL serum
Container
red top tube (no gel)
Causes for Rejection
Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Cyclobenzaprine, Serum or Plasma
Labcorp
Carbamazepine and Carbamazepine-10,11 Epoxide, Serum or Plasma
Labcorp
Tramadol and Metabolite, Quantitative, Serum or Plasma
ARUP Laboratories
Benzodiazepines, Serum or Plasma, Quantitative
ARUP Laboratories
Clobazam, Serum or Plasma
Labcorp
Temazepam, Serum or Plasma
Labcorp
Amobarbital, Serum or Plasma
Labcorp
Baclofen Quantitative, Serum or Plasma
ARUP Laboratories
Meperidine/Normeperidine, Serum or Plasma
Labcorp